Stocks in the news: RIL, Wipro, Tata Motors, Indiabulls Ventures and Axis Bank

Nifty futures on the Singapore Exchange were trading 1.50 points, or 0.01 per cent, down at 10,598.50, indicating a flat start for the Nifty50 on Wednesday.

Asian peers including Hang Seng, Nikkei and Shanghai were trading up 2 per cent higher in the morning trade.

Here's a look at the top stocks that may hog the limelight in today's session:


Reliance Industries: Reliance Jio Infocomm, telecom arm of RIL, said its board has approved schemes to spin off the company’s fibre and tower assets to separate entities.

Axis Bank: Promoter Life Insurance Corporation sold 15.74 lakh shares from December 7-10, according the BSE website.

Wipro: The company said it has set up an automotive innovation center in Detroit, US that will help the IT major deepen its relationship with the Motor City's automotive community.

Unichem Laboratories: Drug firm Unichem Laboratories said it has received a tentative nod from the US health regulator for generic Tadalafil tablets used for treatment of erectile dysfunction.

Tata Motors: The auto company said it has launched top of the line variant of its entry level model Tiago priced between Rs 5.57-6.38 lakh (ex-showroom Delhi).

Usha Martin: The Competition Commission has cleared Tata Sponge Iron’s acquisition of steel business of Usha Martin for Rs 4,300-4,700 crore.

Aurobindo Pharma: Drug firm Aurobindo Pharma said its arm Helix Healthcare BV has entered into a pact with Shandong Luoxin Pharmaceutical Group Stock Co to establish a JV firm in China to manufacture nebuliser inhaler and other products for China, the US and the EU.

Indiabulls Ventures: Indiabulls Ventures promoter Sameer Gehlaut and five other promoter entities have settled a Sebi probe into the alleged violation of ‘takeover regulations’ after paying Rs 48 lakh towards settlement fee.

Zydus Wellness: The Competition Commission Tuesday said it has approved Zydus-Cadila's deal to acquire Heinz India consumer wellness business that includes popular brands like Complan and Glucon D. Zydus Wellness jointly with Cadila Healthcare had signed definitive pacts to acquire Heinz India for Rs 4,595 crore that includes net working capital of Rs 40 crore, cash of Rs 15 crore and assumes no debt.